Palleon Pharmaceuticals is the leading biotechnology company focused on developing Glyco-Immune Checkpoint inhibitors to treat cancer.

Biotechnology

Palleon Pharmaceuticals

Palleon Pharmaceuticals' headquarters in Waltham, MA, United States

Jim Broderick

Stefani Wolff

Li Peng

Paul Crocker

Stephan von Gunten

James Paulson

Jeffrey Ravetch

Rakesh Dixit

Peter Murray

Rob Kramer

Denis Patrick

Rajeev Dadoo

Deepa Pakianathan

Karan Takhar

David Johnson

Alan Colowick

Carolyn Bertozzi

The Board Membership team at Palleon Pharmaceuticals provides strategic oversight, governance, and expert guidance to ensure the company's mission of developing Glyco-Immune Checkpoint inhibitors for cancer treatment is successfully achieved. Members bring diverse insights and maintain accountability to stakeholders, driving forward the company's objectives with integrity and vision.

Board Membership

The Scientific Team at Palleon Pharmaceuticals conducts cutting-edge research and development focused on Glyco-Immune Checkpoint inhibitors to combat cancer. This multidisciplinary team, which includes senior scientific advisors and R&D experts, collaborates on preclinical and clinical studies, engages in detailed analytical and formulation development, and contributes to the overall scientific strategy guiding Palleon's innovative treatment solutions.

Scientific Team

This department conducts scientific research and develops innovative solutions to advance the organization's goals.

Research and Development

This department oversees and optimizes the operational processes and strategies to enhance overall business efficiency.

Business Operations

The Leadership Team at Palleon Pharmaceuticals is responsible for setting the strategic direction and vision of the company, driving innovation in glyco-immune checkpoint inhibitor development, and ensuring successful execution of research and clinical initiatives. Comprising influential leaders such as the CEO, Chief Medical Officer, and Chief Scientific Officer, the team collaborates to advance cutting-edge cancer treatments while overseeing operations, regulatory compliance, and stakeholder engagement.

Leadership Team

The Business Development and Operations team at Palleon Pharmaceuticals identifies strategic partnerships, manages laboratory activities, oversees clinical trials and data management, ensures seamless operations and financial health, and handles the chemistry, manufacturing, and controls (CMC) processes to advance the development of Glyco-Immune Checkpoint inhibitors for cancer treatment.

Palleon Pharmaceuticals

Org chart

Board & advisors

Teams

Board Membership

Scientific Team

Research and Development

Business Operations

Leadership Team

Business Development and Operations

Offices

Palleon Pharmaceuticals

Org chart

Board & advisors

Teams

Board Membership

Scientific Team

Research and Development

Business Operations

Leadership Team

Business Development and Operations

Offices

Related companies